Last $1.90 USD
Change Today +0.04 / 2.15%
Volume 54.1K
As of 8:10 PM 09/2/14 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Anthony P. Furnary M.D.

Member of Medical Advisory Board, Echo Therapeutics, Inc.
AgeTotal Calculated CompensationThis person is connected to 11 board members in 1 different organizations across 1 different industries.

See Board Relationships
----

Background*

Dr. Anthony P. Furnary, M.D. serves as the Associate Director of the Albert Starr Academic Center at Providence St. Vincent Medical Center in Portland, Oregon. Dr. Furnary serves as Director of Cardiovascular Surgical Research at Oregon Medical Laser Center, and Director of the Portland Diabetes Project. Dr. Furnary has been a Member of Medical Advisory Board of Echo Therapeutics, Inc. since May 2008. Dr. Furnary served as a Member of Scientific Advisory Board of GlucoLight ...

Read Full Background

Corporate Headquarters*

8 Penn Center
Philadelphia, Pennsylvania 19103

United States

Phone: 215-717-4100
Fax: --

Board Members Memberships*

There is no Board Members Memberships data available.

Education*

There is no Education data available.

Other Affiliations*

Annual Compensation*

There is no Annual Compensation data available.

Stock Options*

There is no Stock Options data available.

Total Compensation*

There is no Total Compensation data available.
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
ECTE:US $1.90 USD +0.04

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Marijn E. Dekkers Ph.D.Chairman of Management Board and Chief Executive Officer
Bayer AG
€2.9M
Alex Gorsky Chairman, Chief Executive Officer, Chairman of Executive Committee and Chairman of Finance Committee
Johnson & Johnson
$1.5M
Miles D. White Chairman, Chief Executive Officer and Chairman of Executive Committee
Abbott Laboratories
$1.9M
Severin Schwan Ph.D.Chief Executive Officer and Director
Roche Holding AG
SFr.5.1M
Compensation as of Fiscal Year 2013.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact ECHO THERAPEUTICS INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.